Dr. Boyd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
77 Lafayette Pl, Suite 301
Greenwich, CT 06830Phone+1 203-863-3700Fax+1 203-863-4626
Summary
- Board Certified Medical Oncology, graduate training nutrition;
Founder and former director of Nutrition Curriculum at Yale School of Medicine; Director of Cancer Nutrition, Yale Health System
Focus on Management of early stage and advanced adult malignancies, integration of diet and lifestyle in cancer survivorship.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1983 - 1986- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1979 - 1982
Weill Cornell MedicineClass of 1979
Columbia University Institute of Human NutritionMS, Nutritional Biochemistry, 1972 - 1975- Cornell UniversityBS, Biological Sciences, Phi Kappa Phi, 1967 - 1971
Certifications & Licensure
NY State Medical License 1980 - 2026
CT State Medical License 1986 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 7 citationsEvaluation of Computational Chemistry Methods: Crystallographic and Cheminformatics Analysis of Aminothiazole MethoximesTulay Ercanli, Donald B. Boyd
Journal of Chemical Information and Modeling. 2005-04-02 - 3 citationsExploration of the conformational space of a polymeric material that inhibits human immunodeficiency virus.Tulay Ercanli, Donald B. Boyd
Journal of Chemical Information and Modeling. 2006-01-05 - 15 citationsSimple structure-based approach for predicting the activity of inhibitors of beta-secretase (BACE1) associated with Alzheimer's disease.Anthony F. Nastase, Donald B. Boyd
Journal of Chemical Information and Modeling. 2012-12-03
Committees
- Environment and Human Health, New Haven,CT, Board Member 2004 - 2014
Professional Memberships
- Member
- Member
- Member
Industry Relationships
- Consultant, MerckImmunotherapy Nonsmall cell lung cancerDisclosure: Paid lecturer2017 - 2020
- Senior Oncology Consultant, VaccinogenAssist in trial development Immune therapy colorectal cancer2015 - 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
